Dexcom DXCM
NASDAQ DXCM
$84.39 -0.14 (-0.16%)
As of: Sep 9, 2026 · 12:00 PM EDT

Dexcom (DXCM) Other Non-Current Assets (2010 - 2026)

Dexcom's (DXCM) quarterly Other Non-Current Assets came in at $273.7 million in Q2 2026, up 55.95% year-over-year from $175.5 million in Q2 2025, and down 4.27% quarter-over-quarter from $285.9 million in Q1 2026.

Analysis

Dexcom (DXCM) Other Non-Current Assets (2010 - 2026) Analysis & Trends

Dexcom (DXCM) has reported Other Non-Current Assets for 17 consecutive years, with $273.7 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Other Non-Current Assets rose 55.95% year-over-year to $273.7 million in Q2 2026; TTM through Jun 2026 was $273.7 million, a 55.95% increase from a year earlier, with the FY2025 full-year figure at $278.7 million, up 61.1% from the prior year.
  • Other Non-Current Assets was $273.7 million for Q2 2026 at Dexcom, down from $285.9 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $285.9 million in Q1 2026 and troughed at $22.8 million in Q1 2022.
  • A 5-year average of $126.8 million and a median of $80.3 million in 2024 frame the typical range for Other Non-Current Assets.
  • The widest YoY moves for Other Non-Current Assets: up 348.57% in 2022, down 6.44% in 2022.
  • Over 5 years, Other Non-Current Assets stood at $47.1 million in 2022, then surged by 59.24% to $75.0 million in 2023, then jumped by 130.67% to $173.0 million in 2024, then soared by 61.1% to $278.7 million in 2025, then dropped by 1.79% to $273.7 million in 2026.
  • The last three Other Non-Current Assets figures came in at $273.7 million (Q2 2026), $285.9 million (Q1 2026), and $278.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Abbott Laboratories 184.62 Bn 179.02 Bn 7.27 Bn -
2 Intuitive Surgical 124.22 Bn 119.01 Bn 1.96 Bn -
3 Medtronic 118.38 Bn 109.56 Bn 6.34 Bn 4.32 Bn
4 Stryker 104.98 Bn 101.51 Bn 4.50 Bn 3.23 Bn
5 Boston Scientific 66.67 Bn 66.13 Bn 3.85 Bn 45.22 Bn
6 Edwards Lifesciences 49.77 Bn 45.52 Bn 1.35 Bn 616.40 Mn
7 Alcon 34.01 Bn 32.56 Bn 1.68 Bn 434.00 Mn
8 Dexcom 32.28 Bn 30.33 Bn 830.00 Mn 273.70 Mn
9 Steris 21.17 Bn 20.69 Bn 684.20 Mn 215.10 Mn
10 Zimmer Biomet Holdings 18.23 Bn 17.82 Bn 1.54 Bn 1.08 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 273.70 Mn
Mar 31, 2026 285.90 Mn
Dec 31, 2025 278.70 Mn
Sep 30, 2025 276.50 Mn
Jun 30, 2025 175.50 Mn
Mar 31, 2025 168.50 Mn
Dec 31, 2024 173.00 Mn
Sep 30, 2024 88.20 Mn
Jun 30, 2024 82.90 Mn
Mar 31, 2024 77.70 Mn
Dec 31, 2023 75.00 Mn
Sep 30, 2023 74.40 Mn
Jun 30, 2023 66.90 Mn
Mar 31, 2023 56.60 Mn
Dec 31, 2022 47.10 Mn
Sep 30, 2022 33.70 Mn
Jun 30, 2022 24.80 Mn
Mar 31, 2022 22.80 Mn
Dec 31, 2021 10.50 Mn
Jun 30, 2021 23.30 Mn